Patrys Limited (ASX:PAB)
Australia · Delayed Price · Currency is AUD 0.0260
0.00 (0.00%)
Apr 15, 2026, 1:58 PM AEST
Patrys Market Cap
Patrys has a market cap or net worth of 13.92 million as of April 17, 2026. Its market cap has increased by 125.60% in one year.
Market Cap
13.92M
Enterprise Value
12.02M
Revenue
100.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 13.92M, a decrease of -85.66%. That is a compound annual growth rate of -9.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 13.92M | 45.90% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Algorae Pharmaceuticals | 24.28M |
| Argenica Therapeutics | 23.76M |
| Noxopharm | 23.04M |
| Neurotech International | 17.13M |
| Bio-Gene Technology | 11.59M |
| Immuron | 11.43M |
| Tissue Repair | 10.28M |
| AdAlta | 10.20M |